Pathogenic bacterium associated with bacterial vaginosis in the vagina

Pathogenic bacteria in the vagina" is not a specific molecular or receptor target but a collective term referring to various anaerobic bacteria implicated in **bacterial vaginosis** (BV)—the most common cause of abnormal vaginal discharge in reproductive-age women. The principal bacterial pathogens associated with BV include *Gardnerella vaginalis*, *Atopobium vaginae*, *Fannyhessea vaginae* (formerly *Atopobium vaginae*), *Prevotella bivia*, and *Sneathia amnii* among others[1][5][9]. These organisms disrupt the normal Lactobacillus-dominated vaginal microbiota, lead to dysbiosis, degrade the protective mucosal barrier, and form polymicrobial biofilms critical to BV pathogenesis[1][5]. Pathogenicity is mediated by virulence factors such as sialidase and vaginolysin (in *G. vaginalis*), which degrade vaginal mucus and epithelial barriers, facilitating infection, chronic inflammation, and increased susceptibility to other reproductive tract diseases[1][5]. While antibiotics such as metronidazole and clindamycin are standard first-line therapies, high rates of BV recurrence and challenges in restoring healthy lactobacilli represent significant safety and therapeutic challenges[4][6][2][8]. **Note:** This is not a valid single-molecule therapeutic target but rather a **heterogeneous group of organisms**. Proper canonical entries should reference individual pathogens (e.g., “Gardnerella vaginalis”)[1][5].

Other names

Pathogenic vaginal bacteriaBV-associated bacteriaAnaerobic bacteria in the vaginaGardnerella vaginalis and associated pathogensBacterial vaginosis pathogens

Antibacterial inhibition of DNA synthesis (nitroimidazoles, e.g., metronidazole, tinidazole, secnidazole); Inhibition of protein synthesis (lincosamides, e.g., clindamycin)